Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Dermatology

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 239 articles: HTML format Text format

Single Articles

March 2010
1. BYUN S , Lee KW, Jung SK, Lee EJ, et al
   Luteolin Inhibits Protein Kinase C{varepsilon} and c-Src Activities and UVB-Induced Skin Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. GRANGE C , Geninatti-Crich S, Esposito G, Alberti D, et al
   Combined Delivery and Magnetic Resonance Imaging of Neural Cell Adhesion Molecule-Targeted Doxorubicin-Containing Liposomes in Experimentally Induced Kaposi's Sarcoma.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. SHROTRIYA S , Kundu JK, Na HK, Surh YJ, et al
   Diallyl Trisulfide Inhibits Phorbol Ester-Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt Signaling.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SEEGER JM , Schmidt P, Brinkmann K, Hombach AA, et al
   The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. JANE-VALBUENA J , Widlund HR, Perner S, Johnson LA, et al
   An Oncogenic Role for ETV1 in Melanoma.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. DUTERTRE M , Lacroix-Triki M, Driouch K, de la Grange P, et al
   Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
   Cancer Res. 2010;70:896-905.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. LAMBER EP , Horwitz AA, Parvin JD
   BRCA1 represses amphiregulin gene expression.
   Cancer Res. 2010;70:996-1005.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MCKEEN HD , Byrne C, Jithesh PV, Donley C, et al
   FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
   Cancer Res. 2010;70:1090-100.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. RANSBURGH DJ , Chiba N, Ishioka C, Toland AE, et al
   Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.
   Cancer Res. 2010;70:988-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
10. SHEN J , Barrios RJ, Jaiswal AK
    Inactivation of the Quinone Oxidoreductases NQO1 and NQO2 Strongly Elevates the Incidence and Multiplicity of Chemically Induced Skin Tumors.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SONG F , Ji P, Zheng H, Song F, et al
    Definition of a Functional Single Nucleotide Polymorphism in the Cell Migration Inhibitory Gene MIIP That Affects the Risk of Breast Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. HUANG X , Gao L, Wang S, McManaman JL, et al
    Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. GUSTAFSSON N , Zhao C, Gustafsson JA, Dahlman-Wright K, et al
    RBCK1 Drives Breast Cancer Cell Proliferation by Promoting Transcription of Estrogen Receptor {alpha} and Cyclin B1.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. TRUITT L , Freywald T, Decoteau J, Sharfe N, et al
    The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. PAPAGEORGIS P , Lambert AW, Ozturk S, Gao F, et al
    Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ARIAZI EA , Brailoiu E, Yerrum S, Shupp HA, et al
    The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. CONFORTI R , Ma Y, Morel Y, Paturel C, et al
    Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
    Cancer Res. 2010;70:490-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. MCCUNE K , Bhat-Nakshatri P, Thorat MA, Nephew KP, et al
    Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
    Cancer Res. 2010;70:685-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CUI Y , Borysova MK, Johnson JO, Guadagno TM, et al
    Oncogenic B-RafV600E Induces Spindle Abnormalities, Supernumerary Centrosomes, and Aneuploidy in Human Melanocytic Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SCHATTON T , Schutte U, Frank NY, Zhan Q, et al
    Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. WANG W , Niendorf KB, Patel D, Blackford A, et al
    Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MA H , Wang Y, Sullivan-Halley J, Weiss L, et al
    Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HARRISON H , Farnie G, Howell SJ, Rock RE, et al
    Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HELD MA , Curley DP, Dankort D, McMahon M, et al
    Characterization of melanoma cells capable of propagating tumors from a single cell.
    Cancer Res. 2010;70:388-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KUMASAKA MY , Yajima I, Hossain K, Iida M, et al
    A novel mouse model for de novo Melanoma.
    Cancer Res. 2010;70:24-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. WANG L , Ellsworth KA, Moon I, Pelleymounter LL, et al
    Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
    Cancer Res. 2010;70:319-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ZHUANG G , Brantley-Sieders DM, Vaught D, Yu J, et al
    Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.
    Cancer Res. 2010;70:299-308.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
28. BROWN KA , Simpson ER
    Obesity and Breast Cancer: Progress to Understanding the Relationship.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. LI SH , Hawthorne VS, Neal CL, Sanghera S, et al
    Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.
    Cancer Res. 2009;69:9163-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. SCHEUER W , Friess T, Burtscher H, Bossenmaier B, et al
    Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models.
    Cancer Res. 2009;69:9330-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. TIAN L , Zhou J, Casimiro MC, Liang B, et al
    Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.
    Cancer Res. 2009;69:9236-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. KIM SS , Cao L, Baek HJ, Lim SC, et al
    Impaired Skin and Mammary Gland Development and Increased {gamma}-Irradiation-Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. BOBISSE S , Rondina M, Merlo A, Tisato V, et al
    Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. MARDILOVICH K , Shaw LM
    Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion.
    Cancer Res. 2009;69:8894-901.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
35. ZHAO L , Li W, Marshall C, Griffin T, et al
    Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. DRIOUCH K , Bonin F, Sin S, Clairac G, et al
    Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis": Reply.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. PATSIALOU A , Wyckoff J, Wang Y, Goswami S, et al
    Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. TAMIMI RM , Colditz GA, Hankinson SE
    Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. KANDA T , Raychoudhuri A, Steele R, Sagartz JE, et al
    MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. CHEN L , Mayer JA, Krisko TI, Speers CW, et al
    Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LOEBINGER MR , Kyrtatos PG, Turmaine M, Price AN, et al
    Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FRASOR J , Weaver A, Pradhan M, Dai Y, et al
    Positive Cross-Talk between Estrogen Receptor and NF-{kappa}B in Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. JEDESZKO C , Victor BC, Podgorski I, Sloane BF, et al
    Fibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma In situ.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. CHEN H , Zhu G, Li Y, Padia RN, et al
    Extracellular Signal-Regulated Kinase Signaling Pathway Regulates Breast Cancer Cell Migration by Maintaining slug Expression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. NGUYEN FT , Zysk AM, Chaney EJ, Kotynek JG, et al
    Intraoperative evaluation of breast tumor margins with optical coherence tomography.
    Cancer Res. 2009;69:8790-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. LIU JW , Sun P, Yan Q, Paller AS, et al
    De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. PLASMEIJER EI , Neale RE, de Koning MN, Quint WG, et al
    Persistence of Betapapillomavirus Infections as a Risk Factor for Actinic Keratoses, Precursor to Cutaneous Squamous Cell Carcinoma.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. YANG G , Thieu K, Tsai KY, Piris A, et al
    Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. KUO PC , Tsao YP, Chang HW, Chen PH, et al
    Breast Cancer Amplified Sequence 2, a Novel Negative Regulator of the p53 Tumor Suppressor.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. PANG H , Flinn R, Patsialou A, Wyckoff J, et al
    Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KIYONO K , Suzuki HI, Matsuyama H, Morishita Y, et al
    Autophagy Is Activated by TGF-{beta} and Potentiates TGF-{beta}-Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
52. GALANZHA EI , Shashkov EV, Spring PM, Suen JY, et al
    In vivo, Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser.
    Cancer Res. 2009;69:7926-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PINNER S , Jordan P, Sharrock K, Bazley L, et al
    Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination.
    Cancer Res. 2009;69:7969-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. JANDUS C , Bioley G, Dojcinovic D, Derre L, et al
    Tumor Antigen-Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. VAN STIPDONK MJ , Badia-Martinez D, Sluijter M, Offringa R, et al
    Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
    Cancer Res. 2009;69:7784-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
56. FLEMING NI , Trivett MK, George J, Slavin JL, et al
    Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Cancer Res. 2009;69:7473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. ANTONESCU CR , Yoshida A, Guo T, Chang NE, et al
    KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.
    Cancer Res. 2009;69:7175-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. YANG J , Price MA, Li GY, Bar-Eli M, et al
    Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. TORCHIA EC , Chen Y, Sheng H, Katayama H, et al
    A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. KIM DJ , Kataoka K, Rao D, Kiguchi K, et al
    Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. SAETROM P , Biesinger J, Li SM, Smith D, et al
    A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. HOLLESTELLE A , Schutte M
    Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CULHANE AC , Quackenbush J
    Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis"
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. DE NICOLO A , Parisini E, Zhong Q, Dalla Palma M, et al
    Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.
    Cancer Res. 2009;69:7030-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. LIU L , Greger J, Shi H, Liu Y, et al
    Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.
    Cancer Res. 2009;69:6871-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
66. KADOTA M , Sato M, Duncan B, Ooshima A, et al
    Identification of Novel Gene Amplifications in Breast Cancer and Coexistence of Gene Amplification with an Activating Mutation of PIK3CA.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. LI CI , Daling JR, Porter PL, Tang MT, et al
    Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor-Specific Subtypes of Contralateral Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. PRATAP J , Imbalzano KM, Underwood JM, Cohet N, et al
    Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. VILLARES GJ , Dobroff AS, Wang H, Zigler M, et al
    Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.
    Cancer Res. 2009;69:6730-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. KHODADOUST MS , Verhaegen M, Kappes F, Riveiro-Falkenbach E, et al
    Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
    Cancer Res. 2009;69:6405-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. THIOLLOY S , Halpern J, Holt GE, Schwartz HS, et al
    Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
    Cancer Res. 2009;69:6747-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. FARATIAN D , Goltsov A, Lebedeva G, Sorokin A, et al
    Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab.
    Cancer Res. 2009;69:6713-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. DICKINSON SE , Melton TF, Olson ER, Zhang J, et al
    Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. PARRA D , Manils J, Castellana B, Vina-Vilaseca A, et al
    Increased Susceptibility to Skin Carcinogenesis in TREX2 Knockout Mice.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. WALIA V , Ding M, Kumar S, Nie D, et al
    hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. MIN C , Yu Z, Kirsch KH, Zhao Y, et al
    A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. PAJIC M , Iyer JK, Kersbergen A, van der Burg E, et al
    Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. ALI S , Heathcote DA, Kroll SH, Jogalekar AS, et al
    The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.
    Cancer Res. 2009;69:6208-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. PETERS AA , Buchanan G, Ricciardelli C, Bianco-Miotto T, et al
    Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
    Cancer Res. 2009;69:6131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. FAN S , Meng Q, Saha T, Sarkar FH, et al
    Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner.
    Cancer Res. 2009;69:6083-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. LIAO HJ , Carpenter G
    Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor.
    Cancer Res. 2009;69:6179-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. MAURER M , Su T, Saal LH, Koujak S, et al
    3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
    Cancer Res. 2009;69:6299-306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. TEOH ML , Fitzgerald MP, Oberley LW, Domann FE, et al
    Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
    Cancer Res. 2009;69:6355-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SONG N , Huang Y, Shi H, Yuan S, et al
    Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
    Cancer Res. 2009;69:6057-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
85. FISTER S , Gunthert AR, Aicher B, Paulini KW, et al
    GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. WELSH MM , Applebaum KM, Spencer SK, Perry AE, et al
    CTLA4 Variants, UV-Induced Tolerance, and Risk of Non-Melanoma Skin Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. KOHLMEYER J , Cron M, Landsberg J, Bald T, et al
    Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. CULLEN M , Seaman S, Chaudhary A, Yang MY, et al
    Host-Derived Tumor Endothelial Marker 8 Promotes the Growth of Melanoma.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. YANG E , Boire A, Agarwal A, Nguyen N, et al
    Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. DEBLOIS G , Hall JA, Perry MC, Laganiere J, et al
    Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor {alpha} as a Determinant of Breast Cancer Heterogeneity.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. POPOV VM , Zhou J, Shirley LA, Quong J, et al
    The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
    Cancer Res. 2009;69:5752-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. BON G , Di Carlo SE, Folgiero V, Avetrani P, et al
    Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Cancer Res. 2009;69:5978-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. CHANG PC , Fitzgerald LD, Van Geelen A, Izumiya Y, et al
    Kruppel-Associated Box Domain-Associated Protein-1 as a Latency Regulator for Kaposi's Sarcoma-Associated Herpesvirus and Its Modulation by the Viral Protein Kinase.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. SURGULADZE D , Deevi D, Claros N, Corcoran E, et al
    Tumor Necrosis Factor-{alpha} and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. KIM SH , Castro F, Paterson Y, Gravekamp C, et al
    High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. MARELLA NV , Malyavantham KS, Wang J, Matsui SI, et al
    Cytogenetic and cDNA Microarray Expression Analysis of MCF10 Human Breast Cancer Progression Cell Lines.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. RAY-COQUARD I , Cropet C, Van Glabbeke M, Sebban C, et al
    Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
    Cancer Res. 2009;69:5383-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
98. HOFFMAN AE , Zheng T, Yi C, Leaderer D, et al
    microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. PINNIX CC , Lee JT, Liu ZJ, McDaid R, et al
    Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. CHAMBERS AF
     MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LIN BC , Suzawa M, Blind RD, Tobias SC, et al
     Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. DI VIZIO D , Kim J, Hager MH, Morello M, et al
     Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. DIMEO TA , Anderson K, Phadke P, Feng C, et al
     A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. XIE Y , Wolff DW, Wei T, Wang B, et al
     Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. FUNASAKA T , Hogan V, Raz A
     Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. NOVAK P , Jensen TJ, Garbe JC, Stampfer MR, et al
     Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization.
     Cancer Res. 2009;69:5251-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. HECK S , Rom J, Thewes V, Becker N, et al
     Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
     Cancer Res. 2009;69:5186-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. RAINA D , Ahmad R, Joshi MD, Yin L, et al
     Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
     Cancer Res. 2009;69:5133-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. BROWN KA , McInnes KJ, Hunger NI, Oakhill JS, et al
     Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. ZHANG H , Xu X, Gajewiak J, Tsukahara R, et al
     Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. HELMS MW , Kemming D, Contag CH, Pospisil H, et al
     TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. BARONE I , Cui Y, Herynk MH, Corona-Rodriguez A, et al
     Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
     Cancer Res. 2009;69:4724-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. MARETZKY T , Le Gall SM, Worpenberg-Pietruk S, Eder J, et al
     Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.
     Cancer Res. 2009;69:4573-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
114. ZHAO X , Graves C, Ames SJ, Fisher DE, et al
     Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-{gamma} Target Gene Carbohydrate Sulfotransferase 10.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. LU J , Steeg PS, Price JE, Krishnamurthy S, et al
     Breast Cancer Metastasis: Challenges and Opportunities.
     Cancer Res. 2009.
     PubMed     Text format     Related articles   
     
     
     
116. SCHINDLER EM , Hindes A, Gribben EL, Burns CJ, et al
     p38{delta} Mitogen-Activated Protein Kinase Is Essential for Skin Tumor Development in Mice.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. JAGER M , Schoberth A, Ruf P, Hess J, et al
     The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2.
     Cancer Res. 2009;69:4270-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. DATTA J , Ghoshal K, Denny WA, Gamage SA, et al
     A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
     Cancer Res. 2009;69:4277-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. SUN W , Kalen AL, Smith BJ, Cullen JJ, et al
     Enhancing the antitumor activity of adriamycin and ionizing radiation.
     Cancer Res. 2009;69:4294-300.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. FRANCOIS V , Ottaviani S, Renkvist N, Stockis J, et al
     The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. KLEMKE CD , Brenner D, Weiss EM, Schmidt M, et al
     Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. DEMICHELE A , Gray R, Horn M, Chen J, et al
     Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. HENNESSY BT , Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, et al
     Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. RAHMAN KW , Banerjee S, Ali S, Ahmad A, et al
     3,3'-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. MILLER TW , Perez-Torres M, Narasanna A, Guix M, et al
     Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. GHOUL A , Serova M, Astorgues-Xerri L, Bieche I, et al
     Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. MILANI M , Rzymski T, Mellor HR, Pike L, et al
     The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. SCHOLL FA , Dumesic PA, Barragan DI, Harada K, et al
     Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
     Cancer Res. 2009;69:3772-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. DEVAUD C , Bilhere E, Loizon S, Pitard V, et al
     Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
     Cancer Res. 2009;69:3971-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. MANNEFELD M , Klassen E, Gaubatz S
     B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
     Cancer Res. 2009;69:4073-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. WILKINS-PORT CE , Ye Q, Mazurkiewicz JE, Higgins PJ, et al
     TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1.
     Cancer Res. 2009;69:4081-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. KIM KY , Baek A, Hwang JE, Choi YA, et al
     Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
     Cancer Res. 2009;69:4018-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. VON MALTZAHN G , Park JH, Agrawal A, Bandaru NK, et al
     Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas.
     Cancer Res. 2009;69:3892-900.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
134. CEDERVALL J , Jamil S, Prasmickaite L, Cheng Y, et al
     Species-Specific In vivo Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. PAMPALAKIS G , Prosnikli E, Agalioti T, Vlahou A, et al
     A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. HU L , Zhu YT, Qi C, Zhu YJ, et al
     Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. CHENG CJ , Lin YC, Tsai MT, Chen CS, et al
     SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer.
     Cancer Res. 2009;69:3634-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. TOYOOKA T , Ibuki Y
     Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
     Cancer Res. 2009;69:3492-500.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. ILIOPOULOS D , Bimpaki EI, Nesterova M, Stratakis CA, et al
     MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.
     Cancer Res. 2009;69:3278-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. FRIEBOES HB , Edgerton ME, Fruehauf JP, Rose FR, et al
     Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. ELSHEIKH SE , Green AR, Rakha EA, Powe DG, et al
     Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. CROWDER RJ , Phommaly C, Tao Y, Hoog J, et al
     PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. IVANOV VN , Zhou H, Partridge MA, Hei TK, et al
     Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. SMALLEY KS , Nathanson KL, Flaherty KT
     Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. WANG MY , Chen PS, Prakash E, Hsu HC, et al
     Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. OHASHI E , Kogai T, Kagechika H, Brent GA, et al
     Activation of the PI3 Kinase Pathway By Retinoic Acid Mediates Sodium/Iodide Symporter Induction and Iodide Transport in MCF-7 Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. SHIRLEY SH , Rundhaug JE, Tian J, Cullinan-Ammann N, et al
     Transcriptional Regulation of Estrogen Receptor-{alpha} by p53 in Human Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. ALLI E , Sharma VB, Sunderesakumar P, Ford JM, et al
     Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. ZIPPRICH J , Terry MB, Liao Y, Agrawal M, et al
     Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the new york site of the breast cancer family registry.
     Cancer Res. 2009;69:2966-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. WORKMAN HC , Sweeney C, Carraway KL 3rd
     The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.
     Cancer Res. 2009;69:2845-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. LIZARRAGA F , Poincloux R, Romao M, Montagnac G, et al
     Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
     Cancer Res. 2009;69:2792-800.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. PLOTNIKOV A , Varghese B, Tran TH, Liu C, et al
     Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
     Cancer Res. 2009;69:3165-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
153. HOLSTEGE H , Joosse SA, van Oostrom CT, Nederlof PM, et al
     High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. KRISHNAMACHARY B , Glunde K, Wildes F, Mori N, et al
     Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. ZHANG Y , Martens JW, Yu JX, Jiang J, et al
     Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. HOELLER C , Richardson SK, Ng LG, Valero T, et al
     In vivo Imaging of Cutaneous T-Cell Lymphoma Migration to the Skin.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. SCHUURHUIS DH , Verdijk P, Schreibelt G, Aarntzen EH, et al
     In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. AZUMA K , Urano T, Horie-Inoue K, Hayashi SI, et al
     Association of Estrogen Receptor {alpha} and Histone Deacetylase 6 Causes Rapid Deacetylation of Tubulin in Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. SCHMIDT M , Hengstler JG, von Torne C, Koelbl H, et al
     Coordinates in the Universe of Node-Negative Breast Cancer Revisited.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. SHEPHARD ND , Abo R, Rigas SH, Frank B, et al
     A Breast Cancer Risk Haplotype in the Caspase-8 Gene.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. KHODAREV NN , Pitroda SP, Beckett MA, Macdermed DM, et al
     MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. NEAL CL , Yao J, Yang W, Zhou X, et al
     14-3-3{zeta} Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. HOFFMAN AE , Zheng T, Stevens RG, Ba Y, et al
     Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. HARLIN H , Meng Y, Peterson AC, Zha Y, et al
     Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. BAILET O , Fenouille N, Abbe P, Robert G, et al
     Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. BROWN JQ , Wilke LG, Geradts J, Kennedy SA, et al
     Quantitative Optical Spectroscopy: A Robust Tool for Direct Measurement of Breast Cancer Vascular Oxygenation and Total Hemoglobin Content In vivo.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. ROBEY IF , Baggett BK, Kirkpatrick ND, Roe DJ, et al
     Bicarbonate increases tumor pH and inhibits spontaneous metastases.
     Cancer Res. 2009;69:2260-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. NARAYAN M , Wilken JA, Harris LN, Baron AT, et al
     Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.
     Cancer Res. 2009;69:2191-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. PARK SA , Na HK, Kim EH, Cha YN, et al
     4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species.
     Cancer Res. 2009;69:2416-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. CHEN RQ , Yang QK, Lu BW, Yi W, et al
     CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.
     Cancer Res. 2009;69:2663-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. SCORTEGAGNA M , Martin RJ, Kladney RD, Neumann RG, et al
     Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition.
     Cancer Res. 2009;69:2638-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. LIU R , Wang L, Chen G, Katoh H, et al
     FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
     Cancer Res. 2009;69:2252-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. XIAN W , Pappas L, Pandya D, Selfors LM, et al
     Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
     Cancer Res. 2009;69:2244-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. SHURIN MR , Potapovich AI, Tyurina YY, Tourkova IL, et al
     Recognition of Live Phosphatidylserine-Labeled Tumor Cells by Dendritic Cells: A Novel Approach to Immunotherapy of Skin Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. YAMAURA M , Mitsushita J, Furuta S, Kiniwa Y, et al
     NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. IORIO MV , Casalini P, Piovan C, Di Leva G, et al
     microRNA-205 Regulates HER3 in Human Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. PELICANO H , Lu W, Zhou Y, Zhang W, et al
     Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. KIESSLING MK , Klemke CD, Kaminski MM, Galani IE, et al
     Inhibition of Constitutively Activated Nuclear Factor-{kappa}B Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. GOBERT M , Treilleux I, Bendriss-Vermare N, Bachelot T, et al
     Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
     Cancer Res. 2009;69:2000-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. XIAO M , Wang C, Zhang J, Li Z, et al
     IFNgamma promotes papilloma development by up-regulating Th17-associated inflammation.
     Cancer Res. 2009;69:2010-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. PARSONS MJ , Patel P, Brat DJ, Colbert L, et al
     Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells.
     Cancer Res. 2009;69:1706-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
182. PARRI M , Taddei ML, Bianchini F, Calorini L, et al
     EphA2 Reexpression Prompts Invasion of Melanoma Cells Shifting from Mesenchymal to Amoeboid-like Motility Style.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. KLEIN RM , Aplin AE
     Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. VANBROCKLIN MW , Verhaegen M, Soengas MS, Holmen SL, et al
     Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. HIRSCHFELD M , Zur Hausen A, Bettendorf H, Jager M, et al
     Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. WU X , Hawse JR, Subramaniam M, Goetz MP, et al
     The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor {alpha} for Degradation in Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. ENDO-MUNOZ L , Dahler A, Teakle N, Rickwood D, et al
     E2F7 Can Regulate Proliferation, Differentiation, and Apoptotic Responses in Human Keratinocytes: Implications for Cutaneous Squamous Cell Carcinoma Formation.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. DEVY L , Huang L, Naa L, Yanamandra N, et al
     Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
     Cancer Res. 2009;69:1517-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. NAGASAKI S , Suzuki T, Miki Y, Akahira J, et al
     17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.
     Cancer Res. 2009;69:1392-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. BURGA LN , Tung NM, Troyan SL, Bostina M, et al
     Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.
     Cancer Res. 2009;69:1273-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. SLOMIANY MG , Grass GD, Robertson AD, Yang XY, et al
     Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.
     Cancer Res. 2009;69:1293-301.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. JORDAN VC
     A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. FERREIRA M , Fujiwara H, Morita K, Watt FM, et al
     An Activating {beta}1 Integrin Mutation Increases the Conversion of Benign to Malignant Skin Tumors.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. SABNIS G , Schayowitz A, Goloubeva O, Macedo L, et al
     Trastuzumab Reverses Letrozole Resistance and Amplifies the Sensitivity of Breast Cancer Cells to Estrogen.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. CHARAFE-JAUFFRET E , Ginestier C, Iovino F, Wicinski J, et al
     Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. TINNIKOV AA , Yeung KT, Das S, Samuels HH, et al
     Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. SUNG B , Murakami A, Oyajobi BO, Aggarwal BB, et al
     Zerumbone Abolishes RANKL-Induced NF-{kappa}B Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer-Induced Bone Loss in Athymic Nude Mice.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. HURST DR , Edmonds MD, Scott GK, Benz CC, et al
     Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. LISSITZKY JC , Parriaux D, Ristorcelli E, Verine A, et al
     Cyclic AMP Signaling as a Mediator of Vasculogenic Mimicry in Aggressive Human Melanoma Cells In vitro.
     Cancer Res. 2009;69:802-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. HONG SW , Kim CJ, Park WS, Shin JS, et al
     p34SEI-1 Inhibits Apoptosis through the Stabilization of the X-Linked Inhibitor of Apoptosis Protein: p34SEI-1 as a Novel Target for Anti-Breast Cancer Strategies.
     Cancer Res. 2009;69:741-746.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. RAO VA , Klein SR, Agama KK, Toyoda E, et al
     The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase II{alpha} in Breast Cancer Cells.
     Cancer Res. 2009;69:948-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. KUZNETSOV SG , Haines DC, Martin BK, Sharan SK, et al
     Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.
     Cancer Res. 2009;69:863-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. MEDAROVA Z , Rashkovetsky L, Pantazopoulos P, Moore A, et al
     Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
     Cancer Res. 2009;69:1182-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. CROSBY ME , Kulshreshtha R, Ivan M, Glazer PM, et al
     MicroRNA regulation of DNA repair gene expression in hypoxic stress.
     Cancer Res. 2009;69:1221-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. CHALUT KJ , Ostrander JH, Giacomelli MG, Wax A, et al
     Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis.
     Cancer Res. 2009;69:1199-204.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
206. BODE AM , Cho YY, Zheng D, Zhu F, et al
     Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. JIN C , Yang YA, Anver MR, Morris N, et al
     Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. HOFFMAN RM
     Comment re: Preclinical model of spontaneous melanoma metastasis.
     Cancer Res. 2009;69:719.
     PubMed     Text format     Related articles   
     
     
     
209. APRELIKOVA O , Pandolfi S, Tackett S, Ferreira M, et al
     Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.
     Cancer Res. 2009;69:616-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. ZHENG H , Gao L, Feng Y, Yuan L, et al
     Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration.
     Cancer Res. 2009;69:449-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. SINGH S , Varney M, Singh RK
     Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.
     Cancer Res. 2009;69:411-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. WEITZBERG E , Larsen F, Lundberg JO
     Comment re: Nitrite activates estrogen receptor-alpha.
     Cancer Res. 2009;69:718.
     PubMed     Text format     Related articles   
     
     
     
213. MANIE E , Vincent-Salomon A, Lehmann-Che J, Pierron G, et al
     High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.
     Cancer Res. 2009;69:663-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. MIRZOEVA OK , Das D, Heiser LM, Bhattacharya S, et al
     Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.
     Cancer Res. 2009;69:565-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. MARTINEZ-IGLESIAS O , Garcia-Silva S, Tenbaum SP, Regadera J, et al
     Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
     Cancer Res. 2009;69:501-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. ZHAO X , Lu L, Pokhriyal N, Ma H, et al
     Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells.
     Cancer Res. 2009;69:483-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. WANG SE , Xiang B, Zent R, Quaranta V, et al
     Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.
     Cancer Res. 2009;69:475-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. ZHANG C , Zhang F, Tsan R, Fidler IJ, et al
     Transforming Growth Factor-{beta}2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. AYALA I , Giacchetti G, Caldieri G, Attanasio F, et al
     Faciogenital Dysplasia Protein Fgd1 Regulates Invadopodia Biogenesis and Extracellular Matrix Degradation and Is Up-regulated in Prostate and Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. SANKPAL NV , Willman MW, Fleming TP, Mayfield JD, et al
     Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. ANDERBERG C , Li H, Fredriksson L, Andrae J, et al
     Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
     Cancer Res. 2009;69:369-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. ISSA A , Le TX, Shoushtari AN, Shields JD, et al
     Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
     Cancer Res. 2009;69:349-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. LUKES L , Crawford NP, Walker R, Hunter KW, et al
     The origins of breast cancer prognostic gene expression profiles.
     Cancer Res. 2009;69:310-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. MCCABE MT , Lee EK, Vertino PM
     A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
     Cancer Res. 2009;69:282-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. SHIN DS , Kim HN, Shin KD, Yoon YJ, et al
     Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
     Cancer Res. 2009;69:193-202.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. JOHNSEN SA , Gungor C, Prenzel T, Riethdorf S, et al
     Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
     Cancer Res. 2009;69:128-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. OCHSNER SA , Steffen DL, Hilsenbeck SG, Chen ES, et al
     GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells.
     Cancer Res. 2009;69:23-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
228. LIN HJ , Zuo T, Lin CH, Kuo CT, et al
     Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells.
     Cancer Res. 2008;68:10257-66.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. LAW JH , Habibi G, Hu K, Masoudi H, et al
     Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
     Cancer Res. 2008;68:10238-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. SALA G , Dituri F, Raimondi C, Previdi S, et al
     Phospholipase Cgamma1 is required for metastasis development and progression.
     Cancer Res. 2008;68:10187-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. BALAN V , Nangia-Makker P, Schwartz AG, Jung YS, et al
     Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.
     Cancer Res. 2008;68:10045-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. XIANG T , Ohashi A, Huang Y, Pandita TK, et al
     Negative Regulation of AKT Activation by BRCA1.
     Cancer Res. 2008;68:10040-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. HOLLAND D , Hoppe-Seyler K, Schuller B, Lohrey C, et al
     Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
     Cancer Res. 2008;68:9964-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. BARRET JM , Kruczynski A, Vispe S, Annereau JP, et al
     F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
     Cancer Res. 2008;68:9845-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. ROKAVEC M , Schroth W, Amaral SM, Fritz P, et al
     A Polymorphism in the TC21 Promoter Associates with an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer.
     Cancer Res. 2008;68:9799-808.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. CHEN Y , Kibriya MG, Jasmine F, Santella RM, et al
     Do Placental Genes Affect Maternal Breast Cancer? Association between Offspring's CGB5 and CSH1 Gene Variants and Maternal Breast Cancer Risk.
     Cancer Res. 2008;68:9729-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. FEJERMAN L , John EM, Huntsman S, Beckman K, et al
     Genetic Ancestry and Risk of Breast Cancer among U.S. Latinas.
     Cancer Res. 2008;68:9723-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. SAXENA NK , Taliaferro-Smith L, Knight BB, Merlin D, et al
     Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor.
     Cancer Res. 2008;68:9712-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. SAWICKI JA
     Fetal microchimerism and cancer.
     Cancer Res. 2008;68:9567-9.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: